Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Stephens & Co. Reiterates Overweight on Avid Bioservices, Maintains $22 Price Target

Stephens & Co. analyst Jacob Johnson reiterates Avid Bioservices (NASDAQ:CDMO) with a Overweight and maintains $22 price target.
byBenzinga Newsdesk
March 14, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Stephens & Co. analyst Jacob Johnson reiterates Avid Bioservices (NASDAQ:CDMO) with a Overweight and maintains $22 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts